3266. Misbranding of Desoxyn Hydrochloride tablets, Combisul tablets, and
Seconal Sodium capsules. U. S. v. William Chester Dickson (Medical
Arts Pharmacy), and Oliver A. Roholt, Sr. Pleas of guilty. William
Chester Dickson fined $150 and Oliver A. Roholt, Sr., fined $25.   (F. D. O.
No. 28154.    Sample Nos. 41071-K, 41072-K, 50629-K to 50632-K, incl.)
INFORMATION FILED :    September 15, 1950, District of Montana, against William
Chester Dickson, trading as the Medical Arts Pharmacy, Great Falls, Mont.,
and Oliver A. Roholt, Sr., a pharmacist.
INTERSTATE SHIPMENT: From the States of Indiana, Washington, and New
Jersey, into the State of Montana, of quantities of Desoxyn Hydrochloride
tablets, Combisul tablets, and Seconal Sodium capsules.
ALLEGED VIOLATION : On or about May 25 and 26, 1949, while the drugs were
being held for sale after shipment in interstate commerce, William Chester
Dickson caused various quantities of the drugs to be repacked and sold without
a prescription, and on May 25, 1949, William Chester Dickson and Oliver A.
Roholt, Sr., caused an additional quantity of Combisul tablets to be repacked
and sold without a prescription, which acts of the defendants resulted in the
repackaged tablets and capsules being misbranded.
NATURE OF CHARGE: Misbranding, Section 502 (b) (1), the repackaged Combisul
tablets and a portion of the repackaged Desoxyn Hydrochloride tablets failed
to bear labels containing the name and place of business of the manufacturer,
packer, or distributor; and, Section 502 (b) (2), all of the repackaged drugs
bore no labels containing statements of the quantity of the contents.
Further misbranding, Section 502 (d), the repackaged Seconal Sodium cap-
sules contained a chemical derivative of barbituric acid, which derivative has
been found to be, and by regulations designated as, habit forming; and the
drug failed to bear a label containing the name, and quantity or proportion
of such derivative and the statement "Warning-May be habit forming."
Further misbranding, Section 502 (f) (1), all of the repackaged drugs failed
to bear labeling containing adequate directions for use; and, Section 502 (f)
(2), the repackaged Desoxyn Hydrochloride tablets and Combisul tablets bore
no labeling containing warnings against use in those pathological conditions
where their use may be dangerous to health, and against unsafe dosage and
methods and duration of administration.
DISPOSITION": September 15, 1950. Pleas of guilty having been entered, the
court fined William Chester Dickson $150 and Oliver A. Roholt, Sr., $25.